Screening for glaucoma in Canada: A systematic review of the literature

Canadian Journal of Ophthalmology

Volumn 41, Issue 6, 2006, Pages 709-721

  Einarson, Thomas R ^a,b   Vicente, Colin ^a   Machado, Márcio ^a,c   Covert, David ^d   Trope, Graham E ^e   Iskedjian, Michael ^a,f  

^a PharmIdeas Research and Consulting Inc   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CHILE   (Chile)

^d ALCON RESEARCH LTD   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f NONE   (Canada)

Author keywords

Economics; Epidemiology; Glaucoma; Ophthalmology; Policy; Prevention; Screening; Systematic review

Indexed keywords

CANADA; COCHRANE LIBRARY; COST EFFECTIVENESS ANALYSIS; EMBASE; GLAUCOMA; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MEDICAL SOCIETY; MEDLINE; PRACTICE GUIDELINE; PUBLICATION; REVIEW; SCREENING TEST; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES;

EID: 33846306714     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1139/I06-064     Document Type: Review

References (58)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80:389-93.
2. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci 1997;38:83-91.
3. Hyman L, Wu SY, Connell AM, et al. Prevalence and causes of visual impairment in the Barbados Eye Study. Ophthalmology 2001;108:1751-6.
4. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J.. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 1991;266:369-74.
5. Coleman AL. Glaucoma. Lancet 1999;354:1803-10.
6. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados eye study: prevalence of open angle glaucoma. Arch Ophthalmol 1994;112:821-9.
7. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada, 1994. Available: http://www.phac-aspc.gc.ca/publicat/clinic-clinique/index.html (accessed 2006 Oct 10).
8. Wilson J, Jungner Y. Principles and Practice of Screening for Disease. Public Health Paper Number 34. Geneva: World Health Organization; 1968.
9. The US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, Md: Williams and Wilkins; 1996.
10. UK National Screening Committee. Second Report of the UK National Screening Committee. 2000. Available: http://www.nsc.nhs.uk/pdfs/secondreport. pdf (accessed 2005 Oct 20).
11. Boivin J, McGregor M, Archer C. Cost effectiveness of screening for primary open angle glaucoma. J Med Screen 1996;3:154-63.
12. Agbeja-Baiyeroju AM, Bekibele CO, Bamgboye EA, Omokhodion F, Oluleye TS. The Ibadan glaucoma study. Afr J Med Med Sci 2003;32:371-6.
13. Chia W-LA, Goldberg I, Bauman A. Evaluation of oculokinetic perimetry. Aust N Z J Ophthalmol 1999;27:306-11.
14. Christoffersen T, Holtedahl K, Fors T, Ringberg U. Tonometry in the general practice setting II: Which cut-off point for referral - for which patients? Acta Ophthalmol (Copenh) 1993;17:109-13.
15. Congdon NG, Quigley HA, Hung PT, Wang TH, Ho TC, Glovinsky Y. Impact of age, various forms of cataract, and visual acuity on whole-field scotopic sensitivity screening for glaucoma in rural Taiwan. Arch Ophthalmol 1995;113:1138-43.
16. Congdon NG, Quigley HA, Hung PT, Wang TH, Ho TC. Screening techniques for angle-closure glaucoma in rural Taiwan. Acta Ophthalmol Scand 1996;74:113-9.
17. Costagliola C, Russo V, Camera A, Scibelli G. The Takagi Automatic Tangent Screen ATS-85 analyzer for the detection of glaucomatous patients. Ann Ophthalmol 1991;23:18-20.
18. Detry-Morel M, Zeyen T, Kestelyn P, Collignon J, Goethals M; Belgian Glaucoma Society. Screening for glaucoma in a general population with the non-mydriatic fundus camera and the frequency doubling perimeter. Eur J Ophthalmol 2004;14:387-93.
19. Devereux JG, Foster PJ, Baasanhu J, et al. Anterior chamber depth measurement as a screening tool for primary angle-closure glaucoma in an East Asian population. Arch Ophthalmol 2000;118:257-63.
20. Greve M, Chisholm IA. Comparison of the oculokinetic perimetry glaucoma screener with two types of visual field analyser. Can J Ophthalmol 1993;28:201-6.
21. Harper RA, Hill AR, Reeves BC. Effectiveness of unsupervised oculokinetic perimetry for detecting glaucomatous visual field defects. Ophthalmic Physiol Opt 1994;14:199-202.
22. Harper RA, Reeves BC. Glaucoma screening: the importance of combining test data. Optom Vis Sci 1999;76:537-43.
23. Harper R, Reeves B. The sensitivity and specificity of direct ophthalmoscopic optic disc assessment in screening for glaucoma: a multivariate analysis. Graefes Arch Clin Exp Ophthalmol 2000;238:949-55.
24. Jackson C, Bullock J, Pitt M, Keogh J, Glasson W, Hirst L. Screening for glaucoma in a Brisbane general practice - the role of tonometry. Aust N Z J Ophthalmol 1995;23:173-8.
25. Klein BE, Meuer SM, Klein R, Dalton DS. A pilot study of glaucoma visual field screening in diabetes. Eur J Ophthalmol 1991;1:111-4.
26. Lester M, Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye 2000;16:44-9.
27. Metheetrairut A, Singalavanija A, Ruangvaravate N, Tuchinda R. Evaluation of screening tests and prevalence of glaucoma: Integrated health research program for Thai elderly. J Med Assoc Thai 2002;85:147-53.
28. Patel KH, Javitt JC, Tielsch JM, Street DA, Katz J, Quigley HA, Sommer A. Incidence of acute angle-closure glaucoma after pharmacologic mydriasis. Am J Ophthalmol 1995;120:709-17.
29. Ralston ME, Choplin NT, Hollenbach KA, Applegate BJ, Henn TW. Glaucoma screening in primary care: the role of noncontact tonometry. J Fam Pract 1992;34:73-7.
30. Rouhiainen H, Terasvirta M. Incidence of open-angle glaucoma and screening of the intraocular pressure with a non-contact tonometer. Acta Ophthalmol 1990;68:344-6.
31. Sarrion Ferre MT, Hervas JM, Blanquer Gregori JJ Mulet Pons MJ, Marin Rueda N, Barea Montoro A. Cribado del glaucoma en pacientes diabeticos mediante el tonometro de Schlortz. [Screening for glaucoma in diabetic patients by using the Schiortz tonometer] [in Spanish] Aten Primaria 1996;17:18-22.
32. Scott I, Quigley H, Vitale S, Glovinsky Y, Mayers H, Stark W. Effect of cataract on a scotopic sensitivity screening test for glaucoma. J Glaucoma 1994;3:286-91.
33. Sim D, Goh L. Screening for glaucoma in the Chinese elderly population in Singapore. Singapore Med J 1999;40:644-7.
34. Sponsel WE, Ritch R, Stamper R, et al. Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol 1995;120:699-708.
35. Tatemichi M, Nakano T, Tanaka K, et al. Performance of glaucoma mass screening with only a visual field test using frequency-doubling technology perimetry. Am J Ophthalmol 2002;134:529-37.
36. Tatemichi M, Nakano T, Tanaka K, et al. Laterality of the performance of glaucoma mass screening using frequency-doubling technology. J Glaucoma 2003;12:221-5.
37. Thomas R, Parikh R, Muliyil J, Bhat S, George R. Validation of test duration as a screening criterion for frequency doubling perimetry. Am J Ophthalmol 2004;137:562-3.
38. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991;134:1102-10.
39. Tjon-Fo-Sang MJ, Lemij HG. The sensitivity and specificity of nerve fiber layer measurements in glaucoma as determined with scanning laser polarimetry. Am J Ophthalmol 1997;123:62-9.
40. Vernon SA, Henry DJ, Jones SJ. Calculating the predictive power of the Henson field screener in a population at risk of glaucomatous field loss. Br J Ophthalmol 1990;74:220-2.
41. Vernon SA, Henry DJ, Cater L, Jones SJ. Screening for glaucoma in the community by non-ophthalmologically trained staff using semi automated equipment. Eye 1990;4:89-97.
42. Vitale S, Smith TD, Quigley T, et al. Screening performance of functional and structural measurements of neural damage in open-angle glaucoma: a case-control study from the Baltimore Eye Survey. J Glaucoma 2000;9:346-56.
43. Wall M, Neahring RK, Woodward KR. Sensitivity and specificity of frequency doubling perimetry in neuro-ophthalmic disorders: a comparison with conventional automated perimetry. Invest Ophthalmol Vis Sci 2002;43:1277-83.
44. Wessels IF, Randhawa RS. Improving the sensitivity of the OKP visual field screening test with a blue stimulus on a dark background. Eye 1996;10:620-5.
45. Williams ZY, Schuman JS, Gamell L, et al. Optical coherence tomography measurement of nerve fiber layer thickness and the likelihood of a visual field defect. Am J Ophthalmol 2002;134:538-46.
46. Gottlieb LK, Schwartz B, Pauker SG. Glaucoma screening. A cost-effectiveness analysis. Surv Ophthalmol 1983;28:206-26.
47. Jones SJ, Vernon SA, Cater L, Henry DJ. Costing a community based screening programme for the detection of glaucoma. Eye 1990;4:98-102.
48. Niessen AG, Langerhorst CT, Geijssen HC, Greve EL. Design of low cost glaucoma screening. Doc Ophthalmol 1997;93:293-315.
49. Tuck MW, Crick RP. The cost-effectiveness of various modes of screening for primary open-angle glaucoma. Ophthalmic Epidemiol 1997;4:3-17.
50. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429-40.
51. American Academy of Ophthalmology. Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern. Available: http://www.aao.org/education/library/ppp/ poags_new.cfm (accessed 2005 Oct 20).
52. American Optometric Association. Recommendations for Regular Optometric Care. St. Louis, Mo: American Optometric Association; 1997. Available: http://www.aoa.org/documents/CPG-1.pdf (accessed 2006 Oct 5).
53. Prevent Blindness America. Glaucoma in America: Early Detection Crucial to Preventing Vision Loss. Available: http://www.preventblindness. org (accessed 2005 Oct 20).
54. Vicente C, Grootendorst P, Marshman J, Einarson TR. Economic evaluation of early treatment for patients with primary open-angle glaucoma. Value Health 2006;9:A142.
55. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003;121:48-56.
56. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-13.
57. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505.
58. Nelson P, Aspinall P, Papasouliotis O, Worton B, O'Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma 2003;12:139-50.